These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 17044017)

  • 1. TANGO is a tumor suppressor of malignant melanoma.
    Arndt S; Bosserhoff AK
    Int J Cancer; 2006 Dec; 119(12):2812-20. PubMed ID: 17044017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of TANGO in colon and hepatocellular carcinomas.
    Arndt S; Bosserhoff AK
    Oncol Rep; 2007 Oct; 18(4):885-91. PubMed ID: 17786351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Hugl-1 is strongly reduced in malignant melanoma.
    Kuphal S; Wallner S; Schimanski CC; Bataille F; Hofer P; Strand S; Strand D; Bosserhoff AK
    Oncogene; 2006 Jan; 25(1):103-10. PubMed ID: 16170365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of TANGO and leukocyte integrin CD11c/CD18 regulate the migration of human monocytes.
    Arndt S; Melle C; Mondal K; Klein G; von Eggeling F; Bosserhoff AK
    J Leukoc Biol; 2007 Dec; 82(6):1466-72. PubMed ID: 17726152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
    Mueller DW; Bosserhoff AK
    Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
    Keller-Melchior R; Schmidt R; Piepkorn M
    J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Dickkopf genes is strongly reduced in malignant melanoma.
    Kuphal S; Lodermeyer S; Bataille F; Schuierer M; Hoang BH; Bosserhoff AK
    Oncogene; 2006 Aug; 25(36):5027-36. PubMed ID: 16568085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenic proteins are overexpressed in malignant melanoma and promote cell invasion and migration.
    Rothhammer T; Poser I; Soncin F; Bataille F; Moser M; Bosserhoff AK
    Cancer Res; 2005 Jan; 65(2):448-56. PubMed ID: 15695386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p54nrb is a new regulator of progression of malignant melanoma.
    Schiffner S; Zimara N; Schmid R; Bosserhoff AK
    Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of integrin alpha10 is induced in malignant melanoma.
    Wenke AK; Kjellman C; Lundgren-Akerlund E; Uhlmann C; Haass NK; Herlyn M; Bosserhoff AK
    Cell Oncol; 2007; 29(5):373-86. PubMed ID: 17726260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAX4 has the potential to function as a tumor suppressor in human melanoma.
    Hata S; Hamada J; Maeda K; Murai T; Tada M; Furukawa H; Tsutsumida A; Saito A; Yamamoto Y; Moriuchi T
    Int J Oncol; 2008 Nov; 33(5):1065-71. PubMed ID: 18949370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
    Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
    Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of ARNT2 gene on invasion and migration of human hepatocellular carcinoma HCCLM6 cell line].
    Li WW; Wu WZ; Liang Y; Xiao CL; Tao ZH; Wang L; Sun HC; Fan J
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):27-31. PubMed ID: 20128965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of EphB6 expression in metastatic melanoma.
    Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
    Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of LIF (leukemia inhibitory factor) expression in malignant melanoma.
    Kuphal S; Wallner S; Bosserhoff AK
    Exp Mol Pathol; 2013 Oct; 95(2):156-65. PubMed ID: 23831429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Status of RASSF1A in uveal melanocytes and melanoma cells.
    Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
    Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of RASSF1A in uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Merhavi-Shoham E; El SD; Binkovsky N; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(6):2611-9. PubMed ID: 22447862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance.
    Schittek B; Psenner K; Sauer B; Meier F; Iftner T; Garbe C
    Int J Cancer; 2007 May; 120(10):2110-8. PubMed ID: 17266041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of antisense tyrosinase-related protein 1 on melanocytes and malignant melanoma cells.
    Li CY; Gao TW; Wang G; Han ZY; Shen Z; Li TH; Liu YF
    Br J Dermatol; 2004 Jun; 150(6):1081-90. PubMed ID: 15214892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological effects induced by insulin-like growth factor binding protein 3 (IGFBP-3) in malignant melanoma.
    Oy GF; Slipicevic A; Davidson B; Solberg Faye R; Maelandsmo GM; Flørenes VA
    Int J Cancer; 2010 Jan; 126(2):350-61. PubMed ID: 19588500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.